IKZF3 amplification frequently occurs in HER2-positive breast cancer and is a potential therapeutic target
Journal article published in 2022 by
Chih-Yi Lin,
Chung-Jen Yu,
Chia-I. Shen,
Chun-Yu Liu,
Ta-Chung Chao,
Chi-Cheng Huang,
Ling-Ming Tseng,
Jiun-I. Lai 
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 